
Colgate-Palmolive (India) Ltd Q4 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- The company aims for growth driven by four pillars: category growth, premiumization, winning in toothbrushes, and building personal care.
- They expect volume growth notably in toothpaste, with optimistic outlook for FY '24 aiming at high single-digit volume-led sales growth particularly in toothpaste.
- Rural consumption is identified as a key trigger for growth, where brushing habits need to improve.
- Plans to double down on driving category volume growth and step up investment and innovation especially in personal care.
- Despite current volume softness in categories like toothbrushes, premiumization offers growth opportunities.
- Category volume has recently been slightly negative (2-3%) but with signs of recovery; urban areas show positive volume growth.
- Advertising and brand relaunches (e.g., Colgate Strong Teeth) are expected to stimulate growth.
- Growth strategy includes simplifying the business to drive efficiency while strengthening core strengths.
See what Colgate-Palmolive (India) Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Colgate-Palmolive (India) Ltd management said on order book — free account, 30 seconds.
Capex plans
YesTrack Colgate-Palmolive (India) Ltd — get its next earnings analysis in your feed
How does Colgate-Palmolive (India) Ltd rank vs peers in Personal Products?
Pro featureHow does Colgate-Palmolive (India) Ltd rank in Personal Products?
Compare Colgate-Palmolive (India) Ltd against every Personal Products company (Q4 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Colgate-Palmolive (India) Ltd's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q4 FY21 earnings call →
- Q4 FY20 earnings call →
Others in Personal Products this season
- Aakaar Medical (Q2 FY27)
Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M
- Recode Studios Ltd (Q4 FY26)
The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…
- Godrej Consumer Products Ltd (Q2 FY27)
Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej
- Anondita Medicare Ltd (Q3 FY26)
Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from